Morgan Fullerton , PhD

​Morgan Fullerton is a lipid biologist whose training in cellular, molecular and biochemical techniques has allowed him to investigate the link between metabolism and immunity in metabolic diseases such as obesity, type 2 diabetes and heart disease. He joined the department of Biochemisry, Microbiology and Immunology, in the Faculty of Medicine, at the University of Ottawa in July of 2014.

Background:
PhD- Department of Human Health and Nutritional Sciences, University of Guelph

​2004 - 2009

 

​After completing a BSc (Hon) in Molecular Biology and Genetics, at the University of Guelph, Morgan transitioned from his undergraduate research project, to a PhD thesis, under the supervision of Dr. Marica Bakovic. Using a novel knock-out mouse model, his doctoral research characterized the importance of phospholipid metabolism and its links to obesity and metabolic disease.

 

Postdoctoral Fellow- Department of Medicine, McMaster University

​2009 - 2014

 

​In the fall of 2009, Morgan began his postdoctoral training in the lab of Dr. Greg Steinberg at McMaster University. Building on previous experience, Morgan focused his efforts toward understanding how the important metabolic protein named AMP-activated protein kinase (AMPK), was regulated during obesity and metabolic stress. Awarded a Canadian Institutes of Health Research Banting Postdoctoral Fellowship in 2011, his interests in lipid metabolism grew to include a key interest in the links between immune cells and metabolic diseases (obesity, type 2 diabetes and heart disease). His research has led to key discoveries as to the mechanisms of two of the most widely prescribed drugs in the world, the anti-inflammatory medication aspirin, and the anti-diabetic drug metformin.

 

In 2013, Morgan joined the lab of Dr. Jonathan Schertzer as a CIHR postdoctoral fellow and contributed to the understanding of how intracellular pattern recognition proteins such as NLRP3 (inflammasome), NOD1 and NOD2 influence metabolism during obesity. This work led to important discoveries that link statin-induced complications with inflammasome activation in adipose tissue and has shed light on the link between gut microflora and metabolism in obesity.

 

Assistant Professor- Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa (July 2014)
 

Originally from the Ottawa region, Morgan joined the University of Ottawa in July of 2014.